×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LENZ – lenz therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LENZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
06:08 pm
lenz
VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight [Yahoo! Finance]
Low
Report
VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight [Yahoo! Finance]
3/20
03:12 pm
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its price target raised by analysts at Citigroup Inc. from $44.00 to $47.00. They now have a "buy" rating on the stock.
Low
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its price target raised by analysts at Citigroup Inc. from $44.00 to $47.00. They now have a "buy" rating on the stock.
3/19
08:11 pm
lenz
LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript [Seeking Alpha]
Medium
Report
LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript [Seeking Alpha]
3/19
04:29 pm
lenz
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/19
04:05 pm
lenz
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
Medium
Report
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
3/18
08:08 am
lenz
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at TD Cowen. They set a "buy" rating and a $60.00 price target on the stock.
Low
Report
LENZ Therapeutics, Inc. (NASDAQ: LENZ) is now covered by analysts at TD Cowen. They set a "buy" rating and a $60.00 price target on the stock.
3/11
08:00 am
lenz
LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025
Low
Report
LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025
3/3
08:34 am
lenz
LENZ Therapeutics to Host Commercial Day on April 15, 2025 [Yahoo! Finance]
Low
Report
LENZ Therapeutics to Host Commercial Day on April 15, 2025 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/27
04:21 pm
lenz
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Medium
Report
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
3/19
04:45 pm
lenz
Form S-8 LENZ Therapeutics, Inc.
Medium
Report
Form S-8 LENZ Therapeutics, Inc.
3/19
04:38 pm
lenz
Form 10-K LENZ Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K LENZ Therapeutics, Inc. For: Dec 31
3/19
04:09 pm
lenz
Form 8-K LENZ Therapeutics, Inc. For: Mar 19
Medium
Report
Form 8-K LENZ Therapeutics, Inc. For: Mar 19
3/7
06:11 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Mar 07 Filed by: Schimmelpennink Evert B.
Medium
Report
Form 4 LENZ Therapeutics, Inc. For: Mar 07 Filed by: Schimmelpennink Evert B.
1/13
05:27 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Olsson Shawn
Medium
Report
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Olsson Shawn
1/13
05:25 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Odrich Marc
Medium
Report
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Odrich Marc
1/13
05:23 pm
lenz
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Chevallard Daniel R.
Medium
Report
Form 4 LENZ Therapeutics, Inc. For: Jan 09 Filed by: Chevallard Daniel R.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: